Peter S. Conti

23.4k total citations · 1 hit paper
429 papers, 15.2k citations indexed

About

Peter S. Conti is a scholar working on Astronomy and Astrophysics, Radiology, Nuclear Medicine and Imaging and Instrumentation. According to data from OpenAlex, Peter S. Conti has authored 429 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Astronomy and Astrophysics, 130 papers in Radiology, Nuclear Medicine and Imaging and 114 papers in Instrumentation. Recurrent topics in Peter S. Conti's work include Stellar, planetary, and galactic studies (165 papers), Astronomy and Astrophysical Research (114 papers) and Astrophysics and Star Formation Studies (72 papers). Peter S. Conti is often cited by papers focused on Stellar, planetary, and galactic studies (165 papers), Astronomy and Astrophysical Research (114 papers) and Astrophysics and Star Formation Studies (72 papers). Peter S. Conti collaborates with scholars based in United States, China and Chile. Peter S. Conti's co-authors include James R. Bading, Ludwig G. Strauss, Zibo Li, Ryan J. Park, Xiaohong Chen, Mian M. Alauddin, Philip Massey, William D. Vacca, Kai Chen and Hossein Jadvar and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Peter S. Conti

412 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The applications of PET in clinical oncology.

1991 698 citations Peter S. Conti et al. PubMed profile →

Peers

Countries citing papers authored by Peter S. Conti

Since Specialization

Citations

This map shows the geographic impact of Peter S. Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Conti more than expected).

Fields of papers citing papers by Peter S. Conti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Conti. The network helps show where Peter S. Conti may publish in the future.

Co-authorship network of co-authors of Peter S. Conti

This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Conti. A scholar is included among the top collaborators of Peter S. Conti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Conti. Peter S. Conti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan 2021 ·Nature Metabolism ·Amrendra Mishra, Hamed Mirzaei, Novella Guidi, Manlio Vinciguerra, Alice Mouton, (unknown), Francesca Rappa, Rosario Barone, Gerardo Navarrete, Min Wei, Sebastian Brandhorst, Stefano Di Biase, Todd E. Morgan, S. Ram Kumar, Peter S. Conti, Matteo Pellegrini, Michel Bernier, Rafael de Cabo, Valter D. Longo	58
2	Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions 2019 ·PMC ·David R. Elmaleh, Martin R. Farlow, Peter S. Conti, Ronald G. Tompkins, (unknown), Rudolph E. Tanzi	1
3	Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions 2019 ·Journal of Alzheimer s Disease ·David R. Elmaleh, Martin R. Farlow, Peter S. Conti, Ronald G. Tompkins, (unknown), Rudolph E. Tanzi	99
4	One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer 2015 ·Cancer Biotherapy and Radiopharmaceuticals ·Hossein Jadvar, (unknown), David I. Quinn, Peter S. Conti	29
5	Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis 2013 ·Clinical Cancer Research ·Ren Liu, Xiu‐Qing Li, Wenming Gao, Yue Zhou, Shiuan Wey, Satyajit K. Mitra, Valery Krasnoperov, Dezheng Dong, Zibo Li, Dan Li, Genyuan Zhu, Stan G. Louie, Peter S. Conti, Amy S. Lee, Parkash S. Gill	151
6	Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs 2013 ·Biomaterials ·(unknown), Xiao Liang, Zibo Li, Yarong Liu, (unknown), Peter S. Conti, Michael K. Wong, Pin Wang	92
7	Changes in regional brain perfusion during functional brain activation: Comparison of [64Cu]-PTSM with [14C]-Iodoantipyrine 2008 ·Brain Research ·Daniel P. Holschneider, Jiongjiong Yang, Theodore R. Sadler, (unknown), (unknown), (unknown), Peter S. Conti, J. M. Maarek	8
8	Mouse Models of Prostate Adenocarcinoma with the Capacity to Monitor Spontaneous Carcinogenesis by Bioluminescence or Fluorescence 2007 ·Cancer Research ·Chun‐Peng Liao, Zhong Chen, (unknown), James R. Bading, Ryan S. Park, Peter S. Conti, Rex Moats, Anton Berns, Shi Wei, Zongxiang Zhou, Alexander Yu. Nikitin, Pradip Roy‐Burman	62
9	Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice 2006 ·Cancer Research ·Nicole M. Sodir, Xuan Chen, Ryan J. Park, (unknown), Peter S. Conti, Rex Moats, James R. Bading, Darryl Shibata, Peter W. Laird	69
10	18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas 2006 ·Nuclear Medicine Communications ·Andrei Iagaru, Sant P. Chawla, Lawrence R. Menendez, Peter S. Conti	67
11	The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. 2005 ·PubMed ·Peter S. Conti, Christine L. White, (unknown), Arturo Molina, (unknown), Paul Foster	42
12	Integrin αβ3-Targeted Imaging of Lung Cancer 2005 ·Neoplasia ·Xiaohong Chen, Eric M. Sievers, Yingping Hou, Ryan J. Park, Michel Tohme, Robert D. Bart, Ross M. Bremner, James R. Bading, Peter S. Conti	149
13	Radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician 2004 ·Seminars in Nuclear Medicine ·Peter S. Conti	7
14	1- m spectroscopy of normal OB stars 1999 ·Monthly Notices of the Royal Astronomical Society ·Peter S. Conti, Ian D. Howarth	9
15	A spectral atlas of hot, luminous stars at 2 microns. 1996 ·Bulletin of the American Astronomical Society ·M. M. Hanson, Peter S. Conti, Marcia Rieke	30
16	Intrinsic Stellar Parameters 1988 ·NASA Special Publication ·Peter S. Conti	1
17	An atlas of high resolution IUE ultraviolet spectra of 14 Wolf-Rayet stars. 1986 ·Astronomy & Astrophysics Supplement Series ·A. J. Willis, K. A. van der Hucht, Peter S. Conti, C. D. Garmany	2
18	The Massive System HD 166734 1978 ·Bulletin of the American Astronomical Society ·Dennis Ebbets, Peter S. Conti	1
19	The Earliest O-Type Stars 1976 ·Bulletin of the American Astronomical Society ·Peter S. Conti, (unknown)	2
20	Spectrum of Nova Delphini. 1968 ·Peter S. Conti, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact